Medical economics

Financial risks posed by unproven stem cell interventions in Japan

The research group led by Professor Misao Fujita conducted a study to estimate the total amount the Japanese government would refund if a patient received unproven cell interventions and applied for a medical expense deduction.

Oncology & Cancer

Crowdfunding helps pay the bills during cancer, but at a price

Crowdfunding has become a means for people with cancer to get help managing the financial impact of their disease. But while there's relief in paying bills, a new study finds that it comes at a cost: a sense of shame and ...

Diseases, Conditions, Syndromes

One in five Americans has an STD: CDC

According to 2018 data, one in five people in the United States probably carries a sexually transmitted infection, the U.S. Centers for Disease Control and Prevention says.

Oncology & Cancer

Predicting breast cancer recurrences

A new tool combining traditional pathology with machine learning could predict which breast cancer patients actually need surgery. The technology, reported in the November issue of American Journal of Physiology—Cell Physiology, ...

page 1 from 5